Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply.

Kazi DS, Moran AE, Bibbins-Domingo K. Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply. JAMA. 2016 Nov 22; 316(20):2152.

2016

https://researcherprofiles.org/profile/1207382

27893125

Kazi DS, Moran AE, Bibbins-Domingo K

Search form